Fintel reports that on October 1, 2024, Citigroup upgraded their outlook for Bio-Rad Laboratories (NYSE:BIO) from Neutral to ...

Fintel reports that on October 1, 2024, Citigroup upgraded their outlook for Bio-Rad Laboratories (NYSE:BIO.B) from Neutral ...

RXNT, a Maryland-based healthcare technology leader, has acquired Scalabull, a nationwide interfacing network that empowers EHR systems to connect with clinical laboratories and radiology facilities, ...

Lundbeck has tapped Charles River Laboratories’ artificial intelligence capabilities to aid the discovery of neuroscience ...

Dr Reddy's Laboratories on Wednesday said it has tied up with Gilead Sciences for the manufacture and commercialisation of ...

Lenacapavir is a US Food and Drug Administration (FDA) approved medication indicated for the treatment of HIV type 1 (HIV-1) ...

DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the ...

The United States Commerce Department announced on Wednesday its plans to award $100 million to boost the use of artificial ...

Gilead Sciences first launched lenacapavir under the brand name Sunlenca in the United States and European markets in 2022. It is a first-in-class HIV-1 capsid inhibitor ...

Quest Diagnostics has announced seven acquisitions this year, including its recent purchase of select lab assets from ...

An Army-developed tool uses a drop of blood to diagnose traumatic brain injuries and could help medics rule out evacuations ...

Podeo is partnering with Dolby Laboratories to integrate Dolby Atmos immersive audio into its platform. This groundbreaking ...